Strucural Formula (3a498c46 5ad2 416a 875e 18e48b586954 01)
Crestor
Product Images NDC 68151-4634
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 68151-4634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure One (3a498c46 5ad2 416a 875e 18e48b586954 02)
Figure Two (3a498c46 5ad2 416a 875e 18e48b586954 03)
The text describes cumulative incidence rates in a study comparing the effectiveness of the drug RSV to a placebo. The study found that RSV had a statistically significant effect (HR 0.56, 95% CI 0.46-0.69, p<0.001) in reducing incidence rates. The number at risk in the study were 8901 individuals who received RSV and 8801 who received the placebo. The data is presented over several years.*
Figure Three (3a498c46 5ad2 416a 875e 18e48b586954 04)
The text describes a study evaluating the effect of a drug on various endpoints in a group of patients. The number of events that occurred in the treatment group and the placebo group were recorded for each endpoint. The primary endpoint was a composite of multiple events, and the treatment group showed a significant reduction in this endpoint compared to placebo. The other endpoints evaluated were cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The number of events and event rates for each endpoint were reported. The definition of cardiovascular death is also provided.*
Label Image (Lbl681514634)
This is a medication label for Crestor, a brand name of the drug rosuvastatin calcium. The medication comes in the form of tablets in 5 mg strength, manufactured by Corden Pharma. The lot number is B0039, and the expiration date is 07/14. It is available only with a prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
